Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Irritable Bowel Syndrome Treatment Market: By Type: IBS-C, IBS-D; By Application: Cardiology, Urology & Nephrology, Oncology, Gastroenterology; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; Industry Events and Developments

Global Irritable Bowel Syndrome Treatment Market Outlook

The global irritable bowel syndrome treatment market attained a value of about USD 2 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of more than 10% to reach USD 3.2 billion in 2026.

 

The market is being driven by the increasing prevalence of target diseases and the expanded use of medicines for such diseases. The global market is being dominated by North America.

 

Irritable Bowel Syndrome Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Properties and Applications

Irritable bowel syndrome is among the most prevalent functional disorders, with an approximate global prevalence of 10-15%. The actual cause of the symptoms is not known, and symptoms may arise from changes in the activity of the brain, nervous system, and the gut. This can affect the regular feeling and function of the bowel.

 

Global Irritable Bowel Syndrome Treatment Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the industry can be divided into IBS-C and IBS-D.

IBS-C can be further divided into:

  • IBS-C Market
  • Linzess/Constella
  • Amitiza
  • Others

IBS-D is further segmented into:

  • Xifaxan
  • Viberzi
  • Others

The industry can be broadly categorised based on its applications into:

  • Cardiology
  • Urology and Nephrology
  • Oncology
  • Gastroenterology
  • Others

The EMR report looks into the regional markets of irritable bowel syndrome treatment like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Irritable Bowel Syndrome Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

Improved marketing of existing products in various regions is likely to boost the demand over the forecast period 2022-2027. The increasing Linzess adoption in the USA, Europe, as well as Japan, has contributed greatly to the growth of revenues. In January 2020, Linzess was approved in China, which is expected to improve the demand further.

IBS’ continually rising economic burden impacts the quality of jobs and results in higher healthcare costs. In addition, this increased awareness of the disease has, therefore, encouraged the growth of the global irritable bowel syndrome treatment industry. However, the high prevalence of anxiety and depression is expected to catalyse the growth of the demand for irritable bowel syndrome over the forecast period.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global irritable bowel syndrome treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
  • Allergan 
  • Astellas Pharma Inc. 
  • Takeda Pharmaceutical Company Limited 
  • AstraZeneca 
  • Sebela Pharmaceuticals Inc. [Sebela International, Ltd]
  • Synergy Pharmaceuticals Inc. [Callisto Pharmaceuticals, Inc.]
  • Synthetic Biologics, Inc. 
  • Bausch Health Companies Inc. 
  • Ardelyx (NASDAQ: ARDX)
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Application, Region
Breakup by Type IBS-C, IBS-D
Breakup by Application Cardiology, Urology & Nephrology, Oncology, Gastroenterology, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Ironwood Pharmaceuticals, Inc. [IRWD (NASDAQ)], Allergan [AGN (NYSE)], Astellas Pharma Inc. [4503 (TYO)], Takeda Pharmaceutical Company Limited [4502 (TYO)], AstraZeneca [AZN (LON)], Sebela Pharmaceuticals Inc. [Sebela International, Ltd], Synergy Pharmaceuticals Inc. [Callisto Pharmaceuticals, Inc.], Synthetic Biologics, Inc. [SYN (NYSEAMERICAN)], Bausch Health Companies Inc. [BHC (TSE)], Ardelyx [ARDX (NASDAQ)], Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

Key Questions Answered in the Report:

  • How has the global irritable bowel syndrome treatment market performed in the previous years (2017-2021)?
  • What is the forecast assessment of the industry for 2022-2027?
  • What are the major drivers of the historical (2017-2021) and forecast (2022-2027) periods?
  • What are the major constraints of the historical (2017-2021) and forecast (2022-2027) periods?
  • What are the major demand indicators of the global irritable bowel syndrome treatment industry?
  • Who are the key players in the global industry?
  • What is the degree of competition in the global irritable bowel syndrome treatment market?
  • What are the major events and developments taking place within the global industry?

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Irritable Bowel Syndrome Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Irritable Bowel Syndrome Treatment Historical Market (2017-2021) 
    8.3    Global Irritable Bowel Syndrome Treatment Market Forecast (2022-2027)
    8.4    Global Irritable Bowel Syndrome Treatment Market by Type
        8.4.1    IBS-C
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
            8.4.1.4    Breakup by Type
                8.4.1.4.1    IBS-C Market
                8.4.1.4.2    Linzess/Constella
                8.4.1.4.3    Amitiza
                8.4.1.4.4    Others
        8.4.2    IBS-D
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Xifaxan 
                8.4.2.4.2    Viberz
                8.4.2.4.3    Others
    8.5    Global Irritable Bowel Syndrome Treatment Market by Application
        8.5.1    Cardiology
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Urology & Nephrology
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Oncology
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Gastroenterology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Others
    8.6    Global Irritable Bowel Syndrome Treatment Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Ironwood Pharmaceutical, Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Allergan
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Astellas Pharma Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Takeda Pharmaceutical Company Limited
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    AstraZeneca
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Sebela Pharmaceuticals Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Synergy Pharmaceutical Inc.
            11.2.7.1    Company Overview
            11.2.7.2    Product Portfolio
            11.2.7.3    Demographic Reach and Achievements
            11.2.7.4    Certifications
        11.2.8    Synthetic Biologics, Inc.
            11.2.8.1    Company Overview
            11.2.8.2    Product Portfolio
            11.2.8.3    Demographic Reach and Achievements
            11.2.8.4    Certifications
        11.2.9    Bausch Health Companies Inc.
            11.2.9.1    Company Overview
            11.2.9.2    Product Portfolio
            11.2.9.3    Demographic Reach and Achievements
            11.2.9.4    Certifications
        11.2.10    Ardelyx
            11.2.10.1    Company Overview
            11.2.10.2    Product Portfolio
            11.2.10.3    Demographic Reach and Achievements
            11.2.10.4    Certifications
        11.2.11    Others
12    Industry Events and Developments


List of Figures and Tables

1.    Global Irritable Bowel Syndrome Treatment Market: Key Industry Highlights, 2017 and 2027
2.    Global Irritable Bowel Syndrome Treatment Historical Market: Breakup by Type (USD Million), 2017-2021
3.    Global Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Type (USD Million), 2022-2027
4.    Global Irritable Bowel Syndrome Treatment Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Irritable Bowel Syndrome Treatment Historical Market: Breakup by Region (USD Million), 2017-2021
7.    Global Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Region (USD Million), 2022-2027
8.    North America Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
9.    North America Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
10.    Europe Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Europe Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Asia Pacific Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Latin America Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Latin America Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Middle East and Africa Irritable Bowel Syndrome Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Middle East and Africa Irritable Bowel Syndrome Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Global Irritable Bowel Syndrome Treatment Market Structure

Analyst Review

Introduction

EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.

Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:

  • Value-added and infallible market intelligence.
  • A holistic understanding of the current and expected market fluctuations through meticulously collected data.
  • Verified information on the probable opportunities and risks in the present and forecasted markets.
  • Validated and thoroughly analysed insights derived from our latest analytical tools and impeccable sources.

Assessment Approach

Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.

Price Assessment

We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.

Market Assessment

Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.

Data Collection

We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.

Primary Research

As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.

Secondary Research

EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.

Other Analyst Tools and Data Models

Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.

Data Prioritisation

Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.

Data Validation

Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.

Exigent Data Assessment

Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.

Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER